Press Release

Binge-eating Disorder Treatment Market to Grow with a CAGR of 7.25% through 2028

Increasing prevalence of binge-eating disorder and rising awareness are factors driving the Global Binge-eating Disorder Treatment Market in the forecast period 2024-2028.

 

According to TechSci Research report, “Binge-eating Disorder Treatment Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2028”, the Global Binge-eating Disorder Treatment Market stood at USD 571.32 million in 2022 and is anticipated to grow with a CAGR of 7.25% in the forecast period, 2024-2028. The global healthcare landscape has witnessed a significant transformation over the past few decades, with growing awareness and understanding of mental health conditions. One such condition that has garnered increased attention is Binge-eating Disorder (BED). There is a growing recognition of the significance of mental health in society, which has led to increased awareness of conditions like BED. As a result, more individuals are seeking help and clinicians are better equipped to diagnose the disorder. The greater awareness is driving demand for effective treatments, thereby fostering market growth.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Binge-eating Disorder Treatment Market.”

 

In recent years, there have been advancements in the development of evidence-based treatments for BED. Cognitive-behavioural therapy (CBT), interpersonal therapy, and medication options have shown promising results in helping individuals manage their symptoms and reduce binge eating episodes. The availability of these effective treatment options has boosted the demand for BED treatment, driving market growth.

Healthcare policy changes, especially in developed countries, have made it easier for individuals to access mental health services, including treatment for BED. The expansion of insurance coverage and the inclusion of mental health services in healthcare packages have made treatment more accessible and affordable for many, further driving market growth. Reducing the stigma associated with mental health conditions, including eating disorders, has encouraged more individuals to seek help. As public discourse around mental health becomes more open and accepting, individuals with BED are more likely to reach out for treatment, contributing to the expansion of the market.

The Global Binge-eating Disorder Treatment Market is segmented into type, distribution channel and company.

Based on distribution channel, the offline segment has emerged as the predominant market leader. Offline distribution channels facilitate the development of personalized treatment plans tailored to the specific needs of each patient. This customization is essential for effective BED treatment, given that the disorder's presentation and underlying causes can vary greatly from one individual to another. In some cases, medication may be prescribed as part of the BED treatment. Offline channels enable physicians to closely monitor the patient's response to medication, make necessary adjustments, and provide support for any side effects or concerns.

Based on region, North America segment is expected to grow during the forecast period.  North America boasts world-class healthcare facilities and expertise, providing the ideal environment for the testing, deployment, and clinical validation of artificial womb technology. Hospitals and research centers in the United States and Canada have the necessary infrastructure and healthcare professionals to support the use of these innovative devices for premature babies and high-risk pregnancies.

The Asia Pacific region is experiencing rapid market growth. Asia Pacific’s strong market presence and strategic geographical location facilitate the global commercialization of artificial womb facilities. This position allows companies in the region to reach both domestic and international markets more effectively, providing a competitive edge that is essential for global market dominance.

 

Major companies operating in Global Binge-eating Disorder Treatment Market are:

  • Viatris Inc.
  • Johnson and Johnson
  • Lupin Ltd.
  • Omeros Corp.
  • Pyramid Healthcare Inc.
  • Sumitomo Pharma Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Eli Lilly and Co
  • Tonix Pharmaceuticals Holding Corp.
  • Tryp Therapeutics Inc.

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

“The Global Binge-eating Disorder Treatment Market is poised for substantial growth in the coming years, driven by increasing awareness of the disorder, advances in treatment options, changes in healthcare policies, and the overall reduction in the stigmatization of mental health issues. As more individuals seek help for BED, and as research continues to enhance our understanding of the condition, the market for effective treatments is likely to expand, offering hope to those affected by this serious mental health disorder.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

Binge-eating Disorder Treatment Market By Type (Antidepressants, Anticonvulsants, Stimulants, Others), By Distribution Channel (Offline, Online), By Region, By Competition Forecast & Opportunities, 2018-2028F”, has evaluated the future growth potential of Global Binge-eating Disorder Treatment Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Binge-eating Disorder Treatment Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant Reports

Binge eating Disorder Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Antidepressants, Anticonvulsants, Stimulants, Others), By Distribution Channel (Offline, Online), By Region and Competition

Healthcare | Jan, 2024

Increasing prevalence of binge-eating disorder and rising awareness are factors driving the Global Binge-eating Disorder Treatment Market in the forecast period 2024-2028.

Relevant News